| 000 | 01841 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515045015.0 | ||
| 264 | 0 | _c20070613 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a0269-9370 | ||
| 024 | 7 |
_a10.1097/QAD.0b013e3280106d6a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcCarthy, Kerrigan M | |
| 245 | 0 | 0 |
_aPopulation-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cNov 2006 |
||
| 300 |
_a2199-206 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xdrug therapy |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCost of Illness |
| 650 | 0 | 4 |
_aCryptococcosis _xdrug therapy |
| 650 | 0 | 4 | _aHIV Seroprevalence |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aMeningitis, Cryptococcal _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPopulation Surveillance |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aSouth Africa _xepidemiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMorgan, Juliette | |
| 700 | 1 | _aWannemuehler, Kathleen A | |
| 700 | 1 | _aMirza, Sara A | |
| 700 | 1 | _aGould, Susan M | |
| 700 | 1 | _aMhlongo, Ntombi | |
| 700 | 1 | _aMoeng, Portia | |
| 700 | 1 | _aMaloba, Bonnie R | |
| 700 | 1 | _aCrewe-Brown, Heather H | |
| 700 | 1 | _aBrandt, Mary E | |
| 700 | 1 | _aHajjeh, Rana A | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 20 _gno. 17 _gp. 2199-206 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0b013e3280106d6a _zAvailable from publisher's website |
| 999 |
_c16659384 _d16659384 |
||